Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pleural fluids associated with chest infection.

Amal Quadri1, Anne H Thomson

  • 1Department of Paediatrics, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.

Paediatric Respiratory Reviews
|November 30, 2002
PubMed
Summary

Pediatric empyema, a complication of pneumonia, requires prompt recognition and treatment. Intrapleural fibrinolytic therapy can improve outcomes by reducing hospital stays and surgical needs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

British Thoracic Society Paediatric Pneumonia Audit: a review of 3 years of data.

Thorax·2013
Same author

Antibiotics for community-acquired pneumonia in children: is intravenous delivery necessary?

Expert review of respiratory medicine·2010
Same author

Palivizumab, pneumococcal and influenza vaccination in cystic fibrosis.

Journal of the Royal Society of Medicine·2009
Same author

Management of community-acquired pneumonia in children.

Paediatric drugs·2007
Same author

Acute bronchiolitis.

BMJ (Clinical research ed.)·2007
Same author

How should we manage empyema: antibiotics alone, fibrinolytics, or primary video-assisted thoracoscopic surgery (VATS)?

Seminars in respiratory and critical care medicine·2007

Area of Science:

  • Pediatric Pulmonology
  • Thoracic Surgery
  • Infectious Diseases

Background:

  • Pleural effusions frequently accompany pneumonias, with a subset progressing to empyema.
  • Optimal management strategies for pediatric empyema are debated, highlighting the need for effective interventions.
  • Early diagnosis and treatment are crucial to prevent increased morbidity associated with delayed therapy.

Purpose of the Study:

  • To review the pathophysiology of pleural fluid in the context of empyema.
  • To discuss the current therapeutic approaches for pediatric empyema.
  • To evaluate the role and efficacy of intrapleural fibrinolytic therapy.

Main Methods:

  • Review of current literature on pediatric empyema management.
  • Analysis of the pathophysiology of pleural fluid dynamics.
  • Evaluation of treatment outcomes, including hospital stay and surgical intervention rates.

Main Results:

  • Conventional treatment with antibiotics and chest tubes may be insufficient for viscous or loculated effusions.
  • Intrapleural fibrinolytic therapy demonstrates potential to shorten hospital stays and decrease surgical intervention necessity.
  • The long-term prognosis for children with parapneumonic empyema is generally excellent, with preserved lung function.

Conclusions:

  • Prompt recognition and management of pediatric empyema are vital for optimal outcomes.
  • Intrapleural fibrinolytic therapy offers a promising adjunct or alternative to conventional management in select cases.
  • Most children with parapneumonic empyema achieve full recovery and maintain normal lung function post-treatment.

Related Experiment Videos